Ketamine for Acute Painful Crisis in Sickle Cell Disease Patients

NACompletedINTERVENTIONAL
Enrollment

278

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

January 10, 2019

Study Completion Date

February 1, 2019

Conditions
Sickle Cell Crisis
Interventions
DRUG

Morphine Group

Patients will receive standard dose of morphine (0.1 mg/kg) in 100 ml normal saline infused over 30 min in addition to standard IV hydration.

DRUG

Ketamine Group

Patients will receive low dose ketamine 0.3 mg/kg in 100ml N.S. infused over 30 min in addition to standard IV hydration

OTHER

standard IV hydration

IV hydration as per our institutional protocol (Lactated Ringer's or NaCl 0.9% solution will be infused at a rate of 2-3 ml/kg/h)

Trial Locations (1)

31952

Imam Abdulrahman Bin Faisal University, Dammam

All Listed Sponsors
lead

Imam Abdulrahman Bin Faisal University

OTHER

NCT03431285 - Ketamine for Acute Painful Crisis in Sickle Cell Disease Patients | Biotech Hunter | Biotech Hunter